Synergy CHC Corporation
06/29/2026 | Press release | Distributed by Public on 06/29/2026 14:15
Proxy Results, Management Change/Compensation (Form 8-K)
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On June 29, 2026, Synergy CHC Corp. (the "Company") held its 2026 annual meeting of stockholders (the "Annual Meeting"). As further discussed below, at the Annual Meeting, the Company's stockholders approved a proposal to amend (the "Amendment") the Synergy CHC Corp. 2024 Equity Incentive Plan (the "2024 Plan") to (i) increase the aggregate number of shares of the Company's common stock, par value $0.00001 per share ("Common Stock"), available for issuance under the 2024 Plan to 150,000,000 shares of Common Stock and (ii) permit repricing of outstanding awards. There were no other changes to the 2024 Plan. The board of directors of the Company had previously approved the Amendment on April 17, 2026.
The summary of the Amendment contained herein does not purport to be complete and is qualified in its entirety by reference to the full text of the Amendment, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated by reference herein.
The disclosure set forth below in Item 5.07 of this Current Report on Form 8-K is incorporated by reference into this Item 5.02.
Item 5.07. Submission of Matters to a Vote of Security Holders.
Summary of Proposals Submitted to Stockholders
At the Annual Meeting, the following proposals were submitted to the stockholders of the Company, as set forth in the Company's definitive proxy statement for the 2026 Annual Meeting filed with the Securities and Exchange Commission on April 30, 2026:
| Proposal 1: | The election of five (5) directors, each to serve until the 2027 annual meeting of stockholders. |
| Proposal 2: | The ratification of the appointment of RBSM LLP ("RBSM") as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. |
| Proposal 3: | The approval of an amendment to the 2024 Plan to (i) increase the number of shares of Common Stock available for issuance under the 2024 Plan to 150,000,000 shares and (ii) permit repricing of outstanding awards. |
| Proposal 4: | The approval of the full issuance of shares of common stock issuable by the Company upon exercise of the Lender Warrant for purposes of complying with Nasdaq Listing Rules 5635(b) and 5635(d). |
| Proposal 5: | The approval of one or more reverse stock splits of our issued and outstanding shares of Common Stock at one or more specific ratios to be determined by the Board, provided that the aggregate ratio of all such reverse stock splits does not exceed 1-for-200. |
Voting Results
On April 24, 2026 (the "Record Date"), there were 14,899,883 shares of Common Stock outstanding and entitled to vote. Of the 14,899,883 votes that were eligible to be cast by the holders of Common Stock at the Annual Meeting, 9,808,119 votes, or approximately 65% of the total, were represented at the Annual Meeting virtually or by proxy, constituting a quorum. The number of votes cast for, against or withheld, as well as abstentions and broker non-votes, if applicable, in respect of each such matter is set forth below:
Synergy CHC Corporation published this content on June 29, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on June 29, 2026 at 20:16 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]